Related Experiment Video
Updated: Aug 11, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy
Eric H Kossoff1, Jane R McGrogan, Renee M Bluml
1John M. Freeman Pediatric Epilepsy Center, Departments of Neurology and Pediatrics, the Johns Hopkins Medical Institutions, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MS 21287-1000, U.S.A. ekossoff@jhmi.edu
Insights
The modified Atkins diet effectively reduced seizures in children with intractable epilepsy. This well-tolerated therapy offers a promising treatment option for pediatric epilepsy management.
Area of Science:
- Pediatric Neurology
- Nutritional Neuroscience
- Epileptology
Background:
- Intractable childhood epilepsy often requires alternative treatment strategies.
- The ketogenic diet is effective but can be difficult to adhere to.
- The modified Atkins diet offers a less restrictive ketogenic approach.
Purpose of the Study:
- To evaluate the efficacy of a modified Atkins diet for children with intractable epilepsy.
- To assess the tolerability and safety of this dietary intervention.
- To determine if the modified Atkins diet can induce ketosis without strict calorie or fluid restrictions.
Main Methods:
- Prospective study of 20 children (aged 3-18) with drug-resistant epilepsy.
- Dietary intervention involved carbohydrate restriction (10 g/day) and encouraged fat intake.
- Monitoring included daily seizure logs, semiweekly urinary ketone measurements, and biochemical assessments.
Main Results:
- All participants achieved moderate ketosis within 4 days.
- 65% of children experienced >50% seizure reduction, with 35% achieving >90% improvement.
- Four children became seizure-free; mean seizure frequency decreased significantly (p=0.005).
- The diet was well-tolerated with no significant changes in weight or creatinine.
Conclusions:
- The modified Atkins diet is a safe and effective treatment for intractable pediatric epilepsy.
- It provides a viable, less restrictive alternative to traditional ketogenic diets.
- This dietary therapy demonstrates significant potential for seizure control in children.
Purpose:
The Atkins diet may induce ketosis as does the ketogenic diet, without restrictions on calories, fluids, protein, or need for an inpatient fast and admission. Our objective was to evaluate the efficacy and tolerability of a modified Atkins diet for intractable childhood epilepsy.
Methods:
Twenty children were treated prospectively in a hospital-based ambulatory clinic from September 2003 to May 2005. Children aged 3-18 years, with at least three seizures per week, who had been treated with at least two anticonvulsants, were enrolled and received the diet over a 6-month period. Carbohydrates were initially limited to 10 g/day, and fats were encouraged. Parents measured urinary ketones semiweekly and recorded seizures daily. All children received vitamin and calcium supplementation.
Results:
In all children, at least moderate urinary ketosis developed within 4 days (mean, 1.9). Sixteen (80%) completed the 6-month study; 14 chose to remain on the diet afterward. At 6 months, 13 (65%) had >50% improvement, and seven (35%) had >90% improvement (four were seizure free). Mean seizure frequency after 6 months was 40 per week (p = 0.005). Over a 6-month period, mean serum blood urea nitrogen increased from 12 to 17 mg/dl (p = 0.01); creatinine was unchanged. Cholesterol increased from 192 to 221 mg/dl, (p = 0.06). Weight did not change significantly (34.0-33.7 kg); only six children lost weight. A stable body mass index over time correlated with >90% improvement (p = 0.004).
Conclusions:
A modified Atkins diet is an effective and well-tolerated therapy for intractable pediatric epilepsy.
More Related Videos
09:57Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Electroconvulsive Therapy
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy ll: Types